HIIFS
INFI

Harel Insurance Investments & Financial Services’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-80,000
Closed -$863K – 892
2021
Q1 		$863K Buy
+80,000
New +$267K 0.02% 396

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
GPC
Guardian Point Capital Charlottesville, Virginia $243M AUM 22.43% 1-Year Est. Return

Harel Insurance Investments & Financial Services's INFI Position: Q2 2021 in Review

Harel Insurance Investments & Financial Services sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2021, closing a stake of 80,000 shares — an estimated $863K sold.

Harel Insurance Investments & Financial Services first reported a position in INFI in Q1 2021 and held it in 1 quarter. The position peaked at $863K in Q1 2021. 97 funds tracked by Wall St. Rank hold INFI as of Q2 2021.

  • Harel Insurance Investments & Financial Services reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 80,000 Infinity Pharmaceuticals, Inc. shares in Q2 2021, an estimated $863K.
  • Harel Insurance Investments & Financial Services first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2021 and held it in 1 quarter.
  • Harel Insurance Investments & Financial Services's Infinity Pharmaceuticals, Inc. position peaked at $863K in Q1 2021.
  • 97 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2021.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2021, filed 26 Jul 2021.